NanoVibronix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NanoVibronix and buy or sell other stocks, ETFs, and their options commission-free!

About NAOV

ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. 

CEO
Doron Robert Besser, MD
CEODoron Robert Besser, MD
Employees
31
Employees31
Headquarters
Tyler, Texas
HeadquartersTyler, Texas
Founded
2003
Founded2003
Employees
31
Employees31

NAOV Key Statistics

Market cap
6.32M
Market cap6.32M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
22.17K
Average volume22.17K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$162.50
52 Week high$162.50
52 Week low
$2.09
52 Week low$2.09

Stock Snapshot

NanoVibronix(NAOV) stock is priced at $6.25, giving the company a market capitalization of 6.32M. It carries a P/E multiple of -0.03.

On 2026-01-04, NanoVibronix(NAOV) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for NanoVibronix(NAOV) stock has reached 0, versus its average volume of 22.17K.

The stock's 52-week range extends from a low of $2.09 to a high of $162.50.

The stock's 52-week range extends from a low of $2.09 to a high of $162.50.

People also own

Based on the portfolios of people who own NAOV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.